Zummo Jacqueline 4
4 · Protara Therapeutics, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Zummo Jacqueline
Chief R&D Officer
Transactions
- Tax Payment
Common Stock
2023-01-03$2.80/sh−2,159$6,045→ 76,798 total
Footnotes (1)
- [F1]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 3, 2022.